Abstract
Contamination by pharmaceuticals is a worldwide concern. Several studies have shown the deleterious effect that these products cause to ecosystems, including human beings. Among the strategies proposed to mitigate this problem are post- consumer drug management programs, mostly based on the concepts of Corporate Social Responsibility, Circular Economy, and Reverse Logistics. Four of these programs stand out, which have been successfully installed in Colombia (Punto Azul), Spain (SIGRE), Mexico (SINGREM) and Portugal (VALORMED). Together they conform the Ibero-American Network of Post-Consumer Drug Programs. This paper provides an overview of the origins of these programs, their current situation, and future projections.
References
Naciones Unidas. Objetivos del Desarrollo Sostenible. [citado el 30 de mayo de 2023] Disponible en: https://www.un.org/es/common-agenda/sustainable-development-goals.
de Oliveira Souza H, dos Santos Costa R, Rabelo Quadra G, dos Santos Fernandez MA. Pharmaceutical pollution and sustainable development goals: Going the right way? Sustainable Chem. Pharm. 2021; 21: 100428. DOI https://doi.org/10.1016/j.scp.2021.100428.
Red Iberoamericana de Programas Posconsumo de Medicamentos (RIPPM). [citado el 30 de mayo de 2023] Disponible en: https://www.redippm.org.
Portafolio. Falsificación de medicamentos, mal que azota a Colombia. [actualizado en 2020; citado el 30 de mayo de 2023] Disponible en: https://www.portafolio.co/economia/falsificacion-de-medicamentos-mal-que-azota-a-colombia-536879.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2023 Spanish Journal of Environmental Health